POST Online Media Lite Edition


Cecilia Gonzalo new managing director at Essex Woodlands

Staff writer |
New York, USA - February 21, 2013, New York, USA - Essex Woodlands, a healthcare growth equity firm, announced the addition of Cecilia Gonzalo as managing director to the healthcare investment team, effective April 2, 2013.

Ms. Gonzalo has 15 years of experience in healthcare investing and international finance and a successful investment track record across a broad range of pharmaceutical and health care services companies. Prior to joining Essex Woodlands, she was a Managing Director for Warburg Pincus, where she focused exclusively on healthcare investments.

Ms. Gonzalo led R&D and commercial due diligence, recruited senior management teams and completed diverse transaction structures, financings and exits, including most recently the sale of healthcare services company LaVie Care Centers and the financing of specialty pharmaceuticals company Inspire Pharmaceuticals.

Ms. Gonzalo also collaborated with the global Warburg Pincus healthcare team to complete the leveraged buyout of global eye health company Bausch + Lomb and worked on the acquisition o ISTA Pharmaceuticals. She served on the Board of Directors of Warburg Pincus healthcare companies, including Allos Therapeutics, Eurand N.V., Ganic Pharmaceuticals, LaVie Care Centers, Prestwick Pharmaceuticals, Rib-X Pharmaceuticals and Talon Therapeutics. She is also a Board member of the Saint Joseph’s University International Business Advisory Board.


Greene County Bancorp appoints Paul Slutzky as chairman
Indivior promotes Ryan Preblick to permanent CFO
Thermo Fisher Scientific appoints R. Alexandra Keith to board
Conformal Medical appoints George Fazio to board
Sierra Nevada Corporation names Janet Kavandi as EVP

What to read next

Essex appoints COO, CFO resigned
United Drug appoints Lisa Ricciardi as non-executive director
Essex Rental president and CEO Ronald Schad to step down